Acid Sphingomyelinase Deficiency (ASMD) Latest Advances
Find the Latest Research About Acid Sphingomyelinase Deficiency (ASMD)
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1988 publications
Correction: Advanced strategies for detecting acid sphingomyelinase deficiency type B with attenuated phenotypes.
Journal: Orphanet journal of rare diseases
Published: November 26, 2025
New multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases.
Journal: Journal of lipid research
Published: October 24, 2025
Pulmonary Manifestations of Lysosomal Storage Disorders in Adults.
Journal: Clinics in chest medicine
Published: October 19, 2025
Lysosomal Storage Disorders.
Journal: Seminars in respiratory and critical care medicine
Published: October 03, 2025
A Retrospective Chart Review Study on the Burden of Illness of Acid Sphingomyelinase Deficiency in Brazil.
Journal: Journal of clinical medicine
Published: September 26, 2025
Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc Analysis.
Journal: Advances in therapy
Published: September 24, 2025
Olipudase alfa treatment for pediatric acid sphingomyelinase deficiency in Egypt: A prospective, observational cohort study with an interventional subgroup.
Journal: Molecular genetics and metabolism reports
Published: September 19, 2025
Suspected Niemann-Pick disease type B with sea-blue histiocytosis after splenectomy: A rare case report.
Journal: Journal of clinical lipidology
Published: September 17, 2025
Exploring the boundaries of Niemann-Pick disease type A/B: a report of a case and review of literature.
Journal: Molecular and cellular pediatrics
Published: August 09, 2025
Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease.
Journal: Neurobiology of disease
Published: July 25, 2025
A suspicion index tool to aid the diagnosis and treatment of ASMD.
Journal: Orphanet journal of rare diseases
Published: July 22, 2025
Identification of Cepharanthine as a Potential Therapy of Acid Sphingomyelinase Deficiency by Reducing Cellular Sphingosylphosphorylcholine.
Journal: Journal of inherited metabolic disease
Published: June 24, 2025
Last Updated: 04/28/2026